4//SEC Filing
Pizzo Philip A. 4
Accession 0000899243-20-017305
CIK 0001629137other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 9:22 PM ET
Size
12.6 KB
Accession
0000899243-20-017305
Insider Transaction Report
Form 4
Pizzo Philip A.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-17+5,247→ 5,247 totalExercise: $64.75Exp: 2030-06-16→ Common Stock (5,247 underlying) - Exercise/Conversion
Common Stock
2020-06-17+4,800→ 4,800 total - Exercise/Conversion
Restricted Stock Units
2020-06-17+4,800→ 0 total→ Common Stock (4,800 underlying) - Award
Restricted Stock Units
2020-06-17+3,037→ 3,037 total→ Common Stock (3,037 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vested in a single installment on June 17, 2020, the date of the Issuer's annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
- [F3]The shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following June 17, 2020 for 11 months and the remaining 1/12th on the earlier of (i) June 17, 2021 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
- [F4]The shares of Common Stock underlying the RSUs vest in a single installment on the earlier of (i) June 17, 2021 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001574286
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 9:22 PM ET
- Size
- 12.6 KB